http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2670503-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21f35ba70c744fe1a2de99e6b9c963cd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0021
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0875
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-12
filingDate 2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1157044daca39d002b30dfded37fd2be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35129502e3ada0824f3193f6d6a2efbf
publicationDate 2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2670503-T3
titleOfInvention System of administration of a therapeutic gas to a patient
abstract A nitric oxide delivery system (22) comprising: an inlet (24) for connecting to a therapeutic gas source (20) comprising nitric oxide; an outlet to connect to a device (18) that introduces the therapeutic gas into a patient (41); a first flow control valve (30) in fluid communication with the inlet and outlet, wherein the first flow control valve (30) administers the therapeutic gas at a first flow rate; a second flow control valve (28) in fluid communication with the inlet and outlet and in parallel to the first flow control valve (30), wherein the second flow control valve (28) administers the therapeutic gas at a second flow rate that is higher than the first flow rate; and a gas control system that administers a dose of therapeutic gas to the patient's inspiratory gas flow through one or more of the first flow control valve and the second flow control valve. characterized in that the first flow control valve (30) provides a therapeutic gas flow of approximately 1 l / min and wherein the second flow control valve (28) provides a therapeutic gas flow of approximately 6 l / min .
priorityDate 2005-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945

Total number of triples: 32.